Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from melanoma cell lines


ABSTRACT: Differential gene expression analysis of parental and resistant sub-lines of melanoma cell lines treated or untreated with PLX4032 Using microarray we sought to obtain a genome-wide profile of differentially expressed genes in parental melanoma cell lines and resistant sub-lines in response to PLX4032 vs DMSO control treatment. Representative parental melanoma cell lines and resistant sub-lines were treated with PLX4032 at 1 uM or DMSO control for 6h. Total RNA was extracted and cDNAs were generated and hybridized onto GeneChip Human Gene 1.0 ST Arrays (Affymetrix).

ORGANISM(S): Homo sapiens

SUBMITTER: Mikyung Lee 

PROVIDER: E-GEOD-24862 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications


Activating B-RAF(V600E) (also known as BRAF) kinase mutations occur in ∼7% of human malignancies and ∼60% of melanomas. Early clinical experience with a novel class I RAF-selective inhibitor, PLX4032, demonstrated an unprecedented 80% anti-tumour response rate among patients with B-RAF(V600E)-positive melanomas, but acquired drug resistance frequently develops after initial responses. Hypotheses for mechanisms of acquired resistance to B-RAF inhibition include secondary mutations in B-RAF(V600E)  ...[more]

Similar Datasets

2010-11-26 | GSE24862 | GEO
2010-12-01 | E-GEOD-25436 | biostudies-arrayexpress
2014-03-06 | E-GEOD-55583 | biostudies-arrayexpress
2014-02-06 | E-GEOD-54711 | biostudies-arrayexpress
2010-07-18 | E-GEOD-20051 | biostudies-arrayexpress
2010-12-01 | GSE25436 | GEO
2014-01-14 | E-GEOD-50681 | biostudies-arrayexpress
2010-11-26 | E-GEOD-24890 | biostudies-arrayexpress
2014-02-06 | GSE54711 | GEO
2020-09-20 | GSE137452 | GEO